☆ 4.7 Letter

Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.
Article Hematology

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure

Anthony Sabulski et al.

Summary: The study identified higher levels of CXCL9, BAFF, and sC5b-9 in patients with GR compared to HCT controls. Patients with GR experienced significantly higher and later fevers in the transplant course. This suggests potential for using interferon, complement, and BAFF inhibitors as therapies for preventing and treating GR after HCT.

BLOOD ADVANCES (2021)

Add to Collection
Article Hematology

Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

Pietro Merli et al.

HAEMATOLOGICA (2019)

Add to Collection
Article Immunology

STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels With Normal Dephosphorylation

Ofer Zimmerman et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Allergy

Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations

Jennifer W. Leiding et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection
Article Hematology

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype

Julie Toubiana et al.

BLOOD (2016)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.